September 20, 2024

Sign official documents

Reed Vancelick

investment thesis

Since post-COVID normalization, DocuSign (NASDAQ: DOCU) has always been a hot topic among investors. They often come under scrutiny for failed attempts to turn around the company’s performance, including replacing senior leadership, developing strategic go-to-market strategies, and failing to recover growth.